awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39696831-CA64A299-EE2E-48E2-AD0E-B9427B46FB87
Q39696831-CA64A299-EE2E-48E2-AD0E-B9427B46FB87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-CA64A299-EE2E-48E2-AD0E-B9427B46FB87
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
P2860
Q39696831-CA64A299-EE2E-48E2-AD0E-B9427B46FB87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-CA64A299-EE2E-48E2-AD0E-B9427B46FB87
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32fa9aeab7a3897bd7e2e9758c991180911562b6
P2860
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.